Bardin Hill Management Partners LP / AIMT
Bardin Hill Management Partners LP’s Aimmune Therapeutics Inc Position
Does Bardin Hill Management Partners LP own Aimmune Therapeutics Inc (AIMT)? Not currently — the last reported position was 305.5K shares worth $11M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q3 2020
Shares
305.5K
% of Portfolio
+2.79%
Quarters Held
1
position exited
Position History AIMT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2020 | 305.5K | $11M | +2.79% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bardin Hill Management Partners LP’s full portfolio or all institutional holders of AIMT.